n(6)-carboxymethyllysine has been researched along with Autoimmune Diabetes in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (18.18) | 18.2507 |
| 2000's | 13 (39.39) | 29.6817 |
| 2010's | 12 (36.36) | 24.3611 |
| 2020's | 2 (6.06) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, CW; Chung, YH; Ha, SK; Han, EH; Huh, YH; Hyon, JY; Jeong Ha, S; Jeong, HG; Jung, SK; Kim, HJ; Kim, Y; Lee, H; Lee, J; Min, JY; Park, J; Yun, SH | 1 |
| Korwar, AM; Zhang, Q | 1 |
| Kabata, K; Matsuda, S; Nagai, R; Shirakawa, JI; Sugawa, H | 1 |
| Dahl-Jørgensen, K; Fagerland, MW; Hanssen, KF; Jørum, E; Karimé, B; Mellgren, SI; Monnier, VM; Sveen, KA | 1 |
| Colhoun, HM; Schalkwijk, CG; Scheijen, JL; Schram, MT; Stehouwer, CD; van Eupen, MG | 1 |
| Cano, A; Ceperuelo-Mallafré, V; Gil, P; González-Clemente, JM; Llauradó, G; Simó, R; Vendrell, J; Vilardell, C | 1 |
| Efstathiou, T; Gratas-Delamarche, A; Groussard, C; Lefeuvre-Orfila, L; Malardé, L; Vincent, S | 1 |
| Borg, DJ; Forbes, JM; Groop, PH; Härkönen, T; Ilonen, J; Knip, M; Ryhänen, SJ; Salonen, KM; Simell, O; Veijola, R | 1 |
| Fonseca, I; Gouveia, C; Henriques, AC; Martins, LS; Noronha, IL; Oliveira, JC; Rodrigues, A; Silva, D; Vizcaíno, JR | 1 |
| Dettoraki, A; Gil, AP; Spiliotis, BE | 1 |
| Cai, W; Chen, X; Mericq, V; Piccardo, C; Striker, GE; Uribarri, J; Vlassara, H; Zhu, L | 1 |
| Aiello, LP; Asztalos, BF; Cavallerano, JD; Doria, A; Keenan, HA; King, GL; Monnier, VM; Schaefer, EJ; Sell, DR; Strauch, CM; Sun, JK | 1 |
| Coughlan, MT; Forbes, JM | 1 |
| Beretta, G; Beyan, H; Boehm, BO; Burger, H; Davidson, HW; Hawa, MI; Hutton, JC; Leslie, RD; Riese, H; Schlosser, M; Snieder, H | 1 |
| Aston, CE; Basu, A; Chirindel, A; Garg, SK; Hammad, SM; Hanssen, KF; Henriksen, T; Jenkins, AJ; Kalyanaraman, V; Lorentzen, B; Lyons, TJ; Menard, MK; Nankervis, AJ; Scardo, JA; Scholz, H; Stanley, JR; Torjesen, PA; Wu, M; Yu, Y | 1 |
| Koo, JR; Vaziri, ND | 1 |
| Hattori, M; He, C; McEvoy, R; Peppa, M; Vlassara, H; Zheng, F | 1 |
| Braun, A; Busch, M; Fleck, C; Franke, S; Müller, A; Müller, UA; Schiel, R; Stein, G | 1 |
| Galler, A; Kiess, W; Kratzsch, J; Müller, G; Münch, G; Schinzel, R | 1 |
| Barto, R; Lieuw-A-Fa, ML; Schalkwijk, CG; Stehouwer, CD; Teerlink, T; Twisk, J; van Hinsbergh, VW | 1 |
| Hwang, JS; Shin, CH; Yang, SW | 1 |
| Bootsma, AH; Chaturvedi, N; Fuller, JH; Schalkwijk, CG; Schram, MT; Stehouwer, CD | 1 |
| Cleary, P; Dahms, W; Genuth, S; Malone, J; Monnier, VM; Sell, DR; Sivitz, W; Sun, W | 1 |
| Iwamoto, Y; Miura, J; Osawa, M; Uchigata, Y; Watanabe, T; Yamamoto, H; Yamamoto, Y; Yonekura, H | 1 |
| Heine, RJ; Niessen, HW; Schalkwijk, CG; Simsek, S; van Deutekom, AW | 1 |
| Ahmed, MU; Baynes, JW; Degenhardt, TP; Fountain, CW; Jenkins, AJ; Lyons, TJ; Perez, C; Reddy, S; Requena, JR; Thorpe, SR | 1 |
| Bangstad, HJ; Berg, TJ; Clausen, JT; Dahl-Jørgensen, K; Hanssen, KF; Torjesen, PA | 1 |
| Hermon, M; Hoeger, H; Lubec, B; Lubec, G | 1 |
| Bretzel, RG; Brownlee, M; Hammes, HP; Lin, J; Schleicher, E | 1 |
| Albano, E; Allochis, G; Bellomo, G; Cusaro, C; Mottaran, E; Rolla, R; Vay, D; Vidali, M | 1 |
| Franke, S; John, U; Kauf, E; Misselwitz, J; Stein, G | 1 |
| Baynes, JW; Dunn, JA; Knecht, KJ; Lyons, TJ; McCance, DR; McFarland, KF; Thorpe, SR | 1 |
| Bailie, KE; Baynes, JW; Dunn, JA; Dyer, DG; Lyons, TJ | 1 |
33 other study(ies) available for n(6)-carboxymethyllysine and Autoimmune Diabetes
| Article | Year |
|---|---|
Mitochondrial carnitine palmitoyltransferase 2 is involved in N
Topics: Animals; Blood Glucose; Carnitine O-Palmitoyltransferase; Cell Line; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Glycated Hemoglobin; Humans; Kidney; Lysine; Male; Membrane Potential, Mitochondrial; Mice, Inbred C57BL; Mitochondria | 2020 |
Comprehensive Quantification of Carboxymethyllysine-Modified Peptides in Human Plasma.
Topics: Diabetes Mellitus, Type 1; Glycation End Products, Advanced; Glycosylation; Humans; Lysine; Peptide Library; Peptides; Tandem Mass Spectrometry | 2021 |
[Preventive Effects of Aphanothece sacrum on Diabetic Cataracts].
Topics: Animals; Cataract; Cyanobacteria; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Glycation End Products, Advanced; Lens, Crystalline; Lysine; Male; Mice, Inbred Strains; Oxidative Stress; Streptozocin; Tandem Mass Spectrometry | 2019 |
Small- and large-fiber neuropathy after 40 years of type 1 diabetes: associations with glycemic control and advanced protein glycation: the Oslo Study.
Topics: Adolescent; Adult; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Follow-Up Studies; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Imidazoles; Lysine; Male; Middle Aged; Nerve Fibers; Pyruvaldehyde; Sensory Thresholds; Young Adult | 2013 |
Plasma levels of advanced glycation endproducts are associated with type 1 diabetes and coronary artery calcification.
Topics: Adult; Arginine; Biomarkers; C-Reactive Protein; Case-Control Studies; Chromatography, High Pressure Liquid; Coronary Artery Disease; Coronary Vessels; Diabetes Mellitus, Type 1; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Pyrimidines; Tomography, X-Ray Computed; Vascular Calcification; Vascular Cell Adhesion Molecule-1; von Willebrand Factor | 2013 |
Advanced glycation end products are associated with arterial stiffness in type 1 diabetes.
Topics: Adult; Aorta; Biomarkers; Blood Glucose; Case-Control Studies; Diabetes Mellitus, Type 1; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Linear Models; Lysine; Male; Middle Aged; Optical Imaging; Pulse Wave Analysis; Skin; Spectrometry, Fluorescence; Vascular Stiffness | 2014 |
Fermented soy permeate reduces cytokine level and oxidative stress in streptozotocin-induced diabetic rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dietary Supplements; Fermentation; Galactose; Glycine max; Inflammation; Interleukins; Isoflavones; Isoprostanes; Lysine; Male; Oligosaccharides; Oxidative Stress; Phytotherapy; Plant Extracts; Rats, Wistar; Superoxide Dismutase; Uric Acid | 2015 |
Decrease in circulating concentrations of soluble receptors for advanced glycation end products at the time of seroconversion to autoantibody positivity in children with prediabetes.
Topics: Autoantibodies; Case-Control Studies; Child; Child, Preschool; Diabetes Mellitus, Type 1; Disease Progression; Down-Regulation; Female; Humans; Infant; Infant, Newborn; Lysine; Male; Prediabetic State; Receptor for Advanced Glycation End Products; Receptors, Immunologic | 2015 |
Advanced Glycation End Products Evolution after Pancreas-Kidney Transplantation: Plasmatic and Cutaneous Assessments.
Topics: Adult; Biopsy; Case-Control Studies; Diabetes Mellitus, Type 1; Female; Glycation End Products, Advanced; Humans; Immunohistochemistry; Immunosuppression Therapy; Kidney Transplantation; Lysine; Male; Middle Aged; Oxygen; Pancreas Transplantation; Prospective Studies; Proteins; Skin; Time Factors | 2016 |
Association between serum levels of the soluble receptor (sRAGE) for advanced glycation endproducts (AGEs) and their receptor (RAGE) in peripheral blood mononuclear cells of children with type 1 diabetes mellitus.
Topics: Adolescent; Child; Cholesterol, LDL; Diabetes Mellitus, Type 1; Female; Humans; Hypochlorous Acid; Leukocytes, Mononuclear; Lysine; Male; Receptor for Advanced Glycation End Products; Receptors, Immunologic | 2009 |
Maternally transmitted and food-derived glycotoxins: a factor preconditioning the young to diabetes?
Topics: Adiponectin; Adolescent; Adult; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glycation End Products, Advanced; Humans; Infant; Infant Food; Infant, Newborn; Insulin; Isoprostanes; Lysine; Pyruvaldehyde; Risk Factors; Young Adult | 2010 |
Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study.
Topics: Aged; Arginine; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Female; Humans; Lysine; Male; Middle Aged | 2011 |
Temporal increases in urinary carboxymethyllysine correlate with albuminuria development in diabetes.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Albuminuria; Animals; Biomarkers; Cytosol; Deoxyguanosine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Gene Expression; Glomerular Filtration Rate; Glycation End Products, Advanced; Kidney Cortex; Lysine; Male; Mitochondria; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Receptors, Immunologic; RNA, Messenger; Streptozocin; Time Factors | 2011 |
Glycotoxin and autoantibodies are additive environmentally determined predictors of type 1 diabetes: a twin and population study.
Topics: Adolescent; Adult; Antibody Specificity; Autoantibodies; Child; Diabetes Mellitus, Type 1; Enzyme-Linked Immunosorbent Assay; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Population Surveillance; Radioimmunoprecipitation Assay; Twins, Dizygotic; Twins, Monozygotic; Young Adult | 2012 |
Reduced soluble receptor for advanced glycation end-products (sRAGE) scavenger capacity precedes pre-eclampsia in Type 1 diabetes.
Topics: Adult; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 1; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique; Glycation End Products, Advanced; Humans; Imidazoles; Linear Models; Lysine; Pre-Eclampsia; Pregnancy; Pregnancy in Diabetics; Prospective Studies; Receptor for Advanced Glycation End Products; Receptors, Immunologic | 2012 |
Effects of diabetes, insulin and antioxidants on NO synthase abundance and NO interaction with reactive oxygen species.
Topics: Animals; Antioxidants; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Insulin; Lysine; Male; Malondialdehyde; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Tyrosine | 2003 |
Fetal or neonatal low-glycotoxin environment prevents autoimmune diabetes in NOD mice.
Topics: Administration, Oral; Aging; Albuminuria; Animals; Animals, Newborn; Blood Glucose; Creatinine; Crosses, Genetic; Diabetes Mellitus, Type 1; Female; Glycation End Products, Advanced; Islets of Langerhans; Lysine; Male; Mice; Pregnancy; Prenatal Exposure Delayed Effects; Pyruvaldehyde | 2003 |
Effect of smoking on risk factors for cardiovascular disease in patients with diabetes mellitus and renal insufficiency.
Topics: Adult; Aged; Arginine; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glycation End Products, Advanced; Homocysteine; Humans; Kidney Transplantation; Lysine; Middle Aged; Renal Dialysis; Renal Insufficiency; Risk Factors; Smoking | 2003 |
Impact of metabolic control and serum lipids on the concentration of advanced glycation end products in the serum of children and adolescents with type 1 diabetes, as determined by fluorescence spectroscopy and nepsilon-(carboxymethyl)lysine ELISA.
Topics: Adolescent; Adult; Age of Onset; Albuminuria; Blood Glucose; Child; Cholesterol; Diabetes Mellitus, Type 1; Female; Glycation End Products, Advanced; Humans; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Lysine; Male; Reference Values; Regression Analysis; Spectrometry, Fluorescence; Triglycerides | 2003 |
Increased levels of N(epsilon)-(carboxymethyl)lysine and N(epsilon)-(carboxyethyl)lysine in type 1 diabetic patients with impaired renal function: correlation with markers of endothelial dysfunction.
Topics: Adult; Aged; Blood Coagulation Factors; C-Reactive Protein; Case-Control Studies; Diabetes Mellitus, Type 1; E-Selectin; Endothelium, Vascular; Female; Glomerular Filtration Rate; Humans; Kidney; Lysine; Male; Middle Aged; Thrombomodulin; Vascular Cell Adhesion Molecule-1 | 2004 |
Clinical implications of N epsilon-(carboxymethyl)lysine, advanced glycation end product, in children and adolescents with type 1 diabetes.
Topics: Adolescent; Biomarkers; Case-Control Studies; Child; Chronic Disease; Diabetes Complications; Diabetes Mellitus, Type 1; Enzyme-Linked Immunosorbent Assay; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Linear Models; Lysine; Male | 2005 |
Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study.
Topics: Adult; Blood Pressure; Case-Control Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Linear Models; Lysine; Male; Middle Aged; Multicenter Studies as Topic; Platelet Activating Factor; Prospective Studies | 2005 |
Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications p
Topics: Adult; Biopsy; Collagen; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Disease Progression; Disease Susceptibility; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Prognosis; Skin; Time Factors | 2005 |
Endogenous secretory receptor for advanced glycation endproducts levels are correlated with serum pentosidine and CML in patients with type 1 diabetes.
Topics: Adolescent; Adult; Arginine; Diabetes Mellitus, Type 1; Female; Glomerular Filtration Rate; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Regression Analysis | 2007 |
Increased Nepsilon-(carboxymethyl)-lysine levels in cerebral blood vessels of diabetic patients and in a (streptozotocin-treated) rat model of diabetes mellitus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Brain; Cerebrovascular Circulation; Child; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Models, Animal; Glycation End Products, Advanced; Humans; Immunohistochemistry; Lysine; Male; Middle Aged; Rats; Rats, Wistar | 2008 |
Carboxymethylethanolamine, a biomarker of phospholipid modification during the maillard reaction in vivo.
Topics: Adult; Diabetes Mellitus, Type 1; Erythrocyte Membrane; Ethanolamines; Female; Gas Chromatography-Mass Spectrometry; Glycation End Products, Advanced; Humans; Hydrolysis; Immune Sera; Lysine; Maillard Reaction; Male; Membrane Lipids; Models, Chemical; Oxidation-Reduction; Phosphatidylethanolamines; Phospholipids | 1997 |
The advanced glycation end product Nepsilon-(carboxymethyl)lysine is increased in serum from children and adolescents with type 1 diabetes.
Topics: Adolescent; Animals; Antibodies, Monoclonal; Child; Diabetes Mellitus, Type 1; Enzyme-Linked Immunosorbent Assay; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lysine; Male; Rabbits; Sensitivity and Specificity | 1998 |
Aromatic hydroxylation in animal models of diabetes mellitus.
Topics: Animals; Arginine; Blood Glucose; Diabetes Mellitus, Type 1; Disease Models, Animal; Female; Fructosamine; Hydroxylation; Kidney; Lysine; Malondialdehyde; Mice; Rats; Rats, Inbred BB; Rats, Sprague-Dawley; Streptozocin; Tyrosine | 1998 |
Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Nepsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations.
Topics: Adult; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Leukocyte Common Antigens; Lysine; Male; Middle Aged; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Pyruvaldehyde; Risk Factors; T-Lymphocytes | 1999 |
Antibodies against advanced glycation end product Nepsilon-(carboxymethyl)lysine in healthy controls and diabetic patients.
Topics: Adult; Aged; Autoantibodies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Female; Glycation End Products, Advanced; Humans; Immunoglobulin G; Lysine; Male; Middle Aged; Serum Albumin | 2000 |
Advanced glycation end products in children with chronic renal failure and type 1 diabetes.
Topics: Adolescent; Arginine; Child; Child, Preschool; Creatinine; Diabetes Mellitus, Type 1; Female; Glycation End Products, Advanced; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lysine; Male; Reference Values | 2002 |
Effect of diabetes and aging on carboxymethyllysine levels in human urine.
Topics: Adolescent; Adult; Aged; Aging; Diabetes Mellitus, Type 1; Humans; Lysine; Middle Aged; Oxidation-Reduction | 1991 |
Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mellitus.
Topics: Arginine; Blood Glucose; Collagen; Diabetes Mellitus, Type 1; Humans; Hyperglycemia; Lysine; Maillard Reaction; Skin | 1991 |